References
1. Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 2003;18:1947-1954.
2. Nevitt MC, Cummings ST, Stone KL, et al. Risk factors for a first-incident radiographic vertebral fracture in women 9 or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res 2005;20:131-140.
3. Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 2005;20:185-194.
4. Cranney A, Jamal SA, Tsang JF, et al. Low bone mineral density and fracture burden in postmenopausal women. CMAJ 2007;177:575-580.
5. Langsetmo L, Goltzman D, Kovacs CS, et al. Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res 2009;24:1515-1522.
6. Looker AC, Melton LJ 3rd, Harris TB, et al. Prevalence and trends in low femur bone density among older US adults: NHANES 2005Y2006 compared with NHANES III. J Bone Miner Res 2010;25:64-71.
7. America’s Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation. Washington, DC: National Osteoporosis Foundation, 2002.
8. Malabanan AO, Rosen HN, Vokes TJ, et al. Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 Official Positions. J Clin Densitom 2013;16:467-471.
10. US Preventive Services Task Force. Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med 2011;154:356-364.
11. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA 2003;290:1729-1738.
12. Kanis JA, Johnell O, Black DM, et al. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone 2003;33:293-300.
13. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998;280:2077-2082.
14. Quandt SA, Thompson DE, Schneider DL, et al. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of j1.6 to j2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc 2005;80:343-349.
15. Siris ES, Simon JA, Barton IP, et al. Effects of risedronate on fracture risk in postmenopausal women with osteopenia. Osteoporos Int 2008;19:681-686.
16. Phillipov G, Seaborn CJ, Phillips PJ. Reproducibility of DXA: potential impact on serial measurements and misclassification of osteoporosis. Osteoporos Int 2001;12:49-54.
17. Gourlay ML, Fine JP, Preisser JS, et al. Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med 2012;366:225-233.
18. Hillier TA, Stone KL, Bauer DC, et al. Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch Intern Med 2007;167:155-160.
19. Berry SD, Samelson EJ, Pencina MJ, et al. Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture. JAMA 2013;310:1256-1262.
20. Berger C, Langsetmo L, Joseph L, et al. Association between change in BMD and fragility fracture in women and men. J Bone Miner Res 2009;24:361-370.
21. Shagina NB, Tolstykh EI, Degteva MO, et al. Cortical bone resorption rate in elderly persons: estimates from long-term in vivo measurements of (90)Sr in the skeleton. Arch Gerontol Geriatr 2012;54:e411-e418.
22. Kijowski R, Tuite M, Kruger D, et al. Evaluation of trabecular microarchitecture in nonosteoporotic postmenopausal women with and without fracture. J Bone Miner Res 2012;27:1494-1500.
23. Ladinsky GA, Vasilic B, Popescu AM, et al. Trabecular structure quantified with the MRI-based virtual bone biopsy in postmenopausal women contributes to vertebral deformity burden independent of areal vertebral BMD. J Bone Miner Res 2008;23:64-74.
24. Bala Y, Zebaze R, Ghasem-Zadeh A, et al. Cortical porosity identifies women with osteopenia at increased risk for forearm fractures. J Bone Miner Res 2014;29:1356-1362.
25. Stein EM, Liu XS, Nickolas TL, et al. Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Miner Res 2010;25:2572-2581.
26. Recommendations for the prevention and treatment of glucocorticoidinduced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 2001;44:1496-1503.
27. Netelenbos JC, Lems WF, Geusens PP, et al. Spine radiographs to improve the identification of women at high risk for fractures. Osteoporos Int 2009;20:1347-1352.
28. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001;285:320-323.
29. Schousboe JT, Nyman JA, Kane RL, et al. Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med 2005;142:734-741.
30. Moriwaki K, Komaba H, Noto S, et al. Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan. J Bone Miner Res 2013;28:395-403.
31. Kanis JA, Oden A, Johansson H, et al. FRAX and its applications to clinical practice. Bone 2009;44:734-734.
32. Baim S, Wilson CR, Lewiecki EM, et al. Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry. J Clin Densitom 2005;8:371-378.
33. Faulkner KG, von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom 1999;2:343-350.
34. Raisz LG. Clinical practice. Screening for osteoporosis. N Engl J Med 2005;353:164-171.
35. Schneyer CR, Lopez H, Concannon M, et al. Assessing population risk for postmenopausal osteoporosis: a new strategy using data from the Behavioral Risk Factor Surveillance System (BRFSS). J Bone Miner Res 2008;23:151-158.